Cardiovascular

Audio Journal of Cardiovascular Medicine: Thrombin Receptor Antagonist: Advantages in Percutaneous Coronary Intervention?

David Moliterno

DAVID MOLITERNO, University of Kentucky, Lexington

REFERENCE: American College of Cardiolgy New Orleans, March 24th Late Breaking Trials
An oral thrombin receptor antagonist, SCH 530348 has proved safe and effective, and may be better than conventional anti-coagulation treatments for patients receiving percutaneous coronary intervention. Results of the TRA-PCI study were presented at the ACC’s New Orleans meeting by David Moliterno who discussed the new data with Peter Goodwin.

Similar Interviews

  • Audio Journal of Cardiovascular Medicine 10.3, May 2004
  • Reporting from: European Society of Cardiology Congress, Munich, August 28-1 September, 2004 Scientific Editors: Michael Petch, Papworth Hospital, Cambridge Man Fai Shiu, Walsgrave Hospital,

  • TRITON-TIMI 38 Prasugrel Or Clopidogrel In Percutaneous Intevention?
  • Gordon Tomaselli Daniel Jones REFERENCE: Late Breaking Clinical Trials 1, American Heart Association Scientific Sessions, 4-7

  • Angioplasty: Best for Rescue After Failed Thrombolysis
  • Anthony H. Gershlick, Leicester University Abstract: N Engl J Med 2005; 353:2758 If your patient with myocardial infarction has been treated with
    1. [...] Original post by admin [...]

      Posted by audio » Blog Archive » Audio Journal of Cardiovascular Medicine: Thrombin Receptor … | March 31, 2007, 7:05 am

    Post a comment

    Subscribe to Audio Medica Podcast